SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bharat Parenterals informs about transcript of earnings conference call

20 May 2026 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Para A of Part A of Schedule III, Bharat Parenterals has informed that it enclosed a copy of transcript of Company’s Operational and Financial Performance for the Quarter and Year Ended on March 31, 2026 (Q4FY26) held on Tuesday, May 19, 2026. The transcript is also uploaded on the Company’s website at www.bplindia.in.

The above information is a part of company’s filings submitted to BSE.

Bharat Parenterals Share Price

1369.00 -11.00 (-0.80%)
05-Jun-2026 10:12 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1792.25
Dr. Reddys Lab 1272.50
Cipla 1391.10
Zydus Lifesciences 1091.00
Lupin 2277.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×